Banerjee Subhashis sold $12K of ARTV
Banerjee Subhashis (Chief Medical Officer) sold 1,100 shares of Artiva Biotherapeutics, Inc. (ARTV) at $11.16 on 2026-09-03.
How this was made
The 30-second read
Why it matters
The transaction is a routine sale with limited market impact.
Market read
Minor insider sale; unlikely to affect price or sector sentiment.
What to watch
The insider still holds 140,947 shares, indicating confidence despite the sale.
Background
Form 4 filing from SEC EDGAR reporting an insider transaction.
Ticker impact
Chief Medical Officer Banerjee Subhashis sold 1,100 shares for $12,271 on 2026-09-03 via an open‑market transaction.
minimal downward pressure, likely negligible
The sale size ($12k) is tiny relative to market cap and insider holdings; no indication of distress.
Market effects
None; biotech sector not affected by a micro insider sale.
None; only a US‑listed micro‑cap is involved.
None
Counterpoint
Even small insider sales can signal concerns; monitor subsequent filings for pattern.
Key entities
- CompanyArtiva Biotherapeutics, Inc.
US‑listed biotech (NASDAQ: ARTV).
- ExecutiveBanerjee Subhashis
Chief Medical Officer of Artiva Biotherapeutics.